Skip to main content
Year archive

Jagsonpal Pharmaceuticals Limited — 2022 filings

All 129 regulatory filings released by Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) in 2022, sourced directly from the official regulator.

129 Filings
2022 Period
2022 filings (129)
Filing Released Lang
Resignation
Regulatory Filings
2022-12-31 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-12-31 English
Related Party Transaction
Regulatory Filings
2022-11-24 English
Pursuant to Regulation 23(9) of the SEBI Listing Regulations, please find enclosed herewith disclosures of related party transactions on consolidated basis in the revised format, as prescribed ....
Regulatory Filings
2022-11-24 English
Press Release for financial results for the quarter and half year ended 30th September, 2022.
Regulatory Filings
2022-11-09 English
Press Release
Regulatory Filings
2022-11-09 English
Financial Results for the quarter and half year ended 30 September, 2022.
Regulatory Filings
2022-11-09 English
Outcome of Board Meeting
Regulatory Filings
2022-11-09 English
OUTCOME OF THE MEETING OF BOARD OF DIRECTORS OF JAGSONPAL PHARMACEUTICALS LIMITED HELD ON NOVEMBER 09TH, 2022.
Regulatory Filings
2022-11-09 English
Board Meeting — Financial results
Regulatory Filings
2022-11-03 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2022 ,inter alia, to consider and approve Standalone Unaudited ....
Regulatory Filings
2022-11-03 English
General updates
Regulatory Filings
2022-10-14 English
Closure of trading window
Regulatory Filings
2022-09-30 English
The Trading Window for dealing in securities of Jagsonpal Pharmaceuticals Limited ("the Company") shall remain closed for Designated Persons and their immediate relative(s) with effect ....
Regulatory Filings
2022-09-30 English
Reply to Clarification Sought
Regulatory Filings
2022-09-20 English
ESOP/ESPS/SBEB Scheme
Regulatory Filings
2022-09-18 English
Intimation of grant of Employee Stock Options
Regulatory Filings
2022-09-18 English
Annual General Meeting
Regulatory Filings
2022-09-15 English
Voting results of 43rd Annual General Meeting in terms of Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
Regulatory Filings
2022-09-15 English
Annual General Meeting
Regulatory Filings
2022-09-15 English
Proceeding of the 43rd Annual General Meeting held on 14th September, 2022.
Regulatory Filings
2022-09-15 English
ESOP/ESPS/SBEB Scheme
Regulatory Filings
2022-08-29 English
Intimation of grant of Employee Stock Options
Regulatory Filings
2022-08-29 English
Newspaper Advertisements
Regulatory Filings
2022-08-24 English
Submission of Copies of Newspaper Advertisements for 43rd Annual General Meeting and Remote E-voting
Regulatory Filings
2022-08-24 English
Annual General Meeting
Regulatory Filings
2022-08-23 English
Notice of Annual General Meeting and Annual Report for the financial year ended 31st March, 2022
Regulatory Filings
2022-08-23 English
Intimation for Notice of Annual General Meeting to be held through Video Conferencing or Other Audio-Visual Means and Record Date for remote E- voting.
Regulatory Filings
2022-08-23 English
Reply to Clarification Sought
Regulatory Filings
2022-08-16 English
Press Release
Regulatory Filings
2022-08-09 English
Press Release on the financial results for the quarter ended 30.06.2022.
Regulatory Filings
2022-08-09 English
Outcome of Board Meeting
Regulatory Filings
2022-08-09 English
Financial results for the quarter ended 30.06.2022 along with the press release and result presentation.
Regulatory Filings
2022-08-09 English
Please find attached the Unaudited Financial Results (Standalone) of the Company along with Limited Review Report of the Statutory Auditors for the quarter ended June 30, 2022, as approved ....
Regulatory Filings
2022-08-09 English
Board Meeting — Financial results
Regulatory Filings
2022-08-04 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2022 ,inter alia, to consider and approve the Unaudited Financial ....
Regulatory Filings
2022-08-04 English
General updates
Regulatory Filings
2022-07-20 English
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30th June, 2022.
Regulatory Filings
2022-07-20 English
General updates
Regulatory Filings
2022-07-16 English
Press Release
Regulatory Filings
2022-07-16 English
Appointment
Regulatory Filings
2022-07-16 English
Appointment
Regulatory Filings
2022-07-16 English
Authorization for determining materiality of an event or information under the SEBI LODR.
Regulatory Filings
2022-07-16 English
Press Release for appointment of Mr. Manish Gupta as the Managing Director of the Company.
Regulatory Filings
2022-07-16 English
Appointment of Statutory Auditors.
Regulatory Filings
2022-07-16 English
Appointment of Mr. Manish Gupta as the Managing Director of the company.
Regulatory Filings
2022-07-16 English
General updates
Regulatory Filings
2022-06-30 English
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-06-30 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Infinity Holdings & PACs
Regulatory Filings
2022-06-29 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aresko Progressive Pvt Ltd
Regulatory Filings
2022-06-29 English
General updates
Regulatory Filings
2022-06-27 English
Share purchase agreement dated 21 February 2022 has been entered into amongst the existing promoters of the Company (being Aresko Progressive Private Limited (acting in capacity as a trustee ....
Regulatory Filings
2022-06-27 English
Open Offer
Regulatory Filings
2022-06-22 English
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Post Offer Advertisement in accordance with Regulation 18(12) of the Securities and Exchange Board of India (Substantial ...
Regulatory Filings
2022-06-22 English
Extra Ordinary Meeting
Regulatory Filings
2022-06-18 English
EGM-Voting Results
Regulatory Filings
2022-06-18 English
Proceeding of the Extra-Ordinary General Meeting held on 17th June, 2022.
Regulatory Filings
2022-06-17 English
Related Party Transaction
Regulatory Filings
2022-06-14 English
Please find enclosed herewith disclosures of related party transactions on consolidated basis, as prescribed under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November ....
Regulatory Filings
2022-06-14 English
Recommendations of the Committee of Independent Directors ('IDC') of Jagsonpal Pharmaceuticals Limited ('Target Company') on the Open Offer (as defined below) made by Infinity Holdings ....
Regulatory Filings
2022-06-06 English
Open Offer
Regulatory Filings
2022-06-06 English
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of the Securities and Exchange Board of India (Substantial ....
Regulatory Filings
2022-06-06 English
Open Offer
Regulatory Filings
2022-06-06 English
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendation of the Committee of Independent Directors ('IDC') on the Open Offer' to the public shareholders ....
Regulatory Filings
2022-06-03 English
Financial Result Updates
Regulatory Filings
2022-05-31 English
General updates
Regulatory Filings
2022-05-31 English
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer to the eligible public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company").
Regulatory Filings
2022-05-31 English
Outcome of Board Meeting
Regulatory Filings
2022-05-30 English
Compliance report
Regulatory Filings
2022-05-30 English
Audited Financial Results for the quarter and financial year ended 31 March, 2022.
Regulatory Filings
2022-05-30 English
This is to intimate that the Board of Directors of the Company at their meeting held today, (i.e. Monday, the 30th Day of May, 2022), commenced at 1200 hours and concluded on 1755 hours ....
Regulatory Filings
2022-05-30 English
Board Meeting — Financial results
Regulatory Filings
2022-05-22 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 ,inter alia, to consider and approve The Standalone Audited ....
Regulatory Filings
2022-05-22 English
Book Closure
Regulatory Filings
2022-05-20 English
Extra Ordinary Meeting
Regulatory Filings
2022-05-20 English
Book Closure for the purpose of EGM: From Friday, June 10, 2022 to Friday, June 17, 2022.
Regulatory Filings
2022-05-20 English
Intimation for Notice of Extra Ordinary General Meeting to be held on 17 June, 2022 at 1100 hours through Video Conferencing or Other Audio-Visual Means, Book Closure and Record Date for ....
Regulatory Filings
2022-05-20 English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars ....
Regulatory Filings
2022-05-16 English
Outcome of Board Meeting
Regulatory Filings
2022-05-13 English
Outcome of the Board Meeting.
Regulatory Filings
2022-05-13 English
Board Meeting — Other business matters
Regulatory Filings
2022-05-04 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2022 ,inter alia, to consider and approve the alteration in ....
Regulatory Filings
2022-05-04 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2022-04-30 English
Submission of Certificate under Sub- Regulation 9 & 10 Regulation 40 of the SEBI (Listing Obligations & Disclosure Requirement) Regulations, 2015 for the year ended 31st March, 2022.
Regulatory Filings
2022-04-26 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasbir Kaur Kochhar
Regulatory Filings
2022-04-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajpal Singh Kochhar
Regulatory Filings
2022-04-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajpal Singh Kochhar
Regulatory Filings
2022-04-20 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Rajpal Singh Kochhar
Regulatory Filings
2022-04-20 English
Compliance Certificate (Pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015) for the half year ended 31ST March, 2022
Regulatory Filings
2022-04-20 English
General updates
Regulatory Filings
2022-04-15 English
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st March, 2022.
Regulatory Filings
2022-04-15 English
Closure of trading window
Regulatory Filings
2022-03-31 English
Closure of trading window.
Regulatory Filings
2022-03-31 English
This is to intimate that the company has received the Draft Letter of Offer (DLOF) in relation to the Open Offer.
Regulatory Filings
2022-03-07 English
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the eligible public shareholders of Jagsonpal Pharmaceuticals Ltd ("Target Company").
Regulatory Filings
2022-03-04 English
Newspaper Advertisements
Regulatory Filings
2022-03-01 English
Intimation for Detailed Public Statement Under Regulations 3(1) and 4 read with Regulations 13(4), 14(3) And 15(2) and other applicable provisions of Securities and Exchange Board of India ....
Regulatory Filings
2022-02-28 English
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulations 3(1) and 4 read with Regulation 13(4), 14(3), 15(2) and other ....
Regulatory Filings
2022-02-28 English
Clarification on Price Movement.
Regulatory Filings
2022-02-28 English
Price movement
Regulatory Filings
2022-02-28 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2022-02-22 English
Investor Presentation
Regulatory Filings
2022-02-22 English
Press Release
Regulatory Filings
2022-02-22 English
Press Release
Regulatory Filings
2022-02-22 English
Agreements/Contracts/Arrangements/ MOU's PARA B
Regulatory Filings
2022-02-22 English
Investor presentation
Regulatory Filings
2022-02-21 English
Intimation for Public Announcement.
Regulatory Filings
2022-02-21 English
DISCLOSURE UNDER REGULATION 30 OF THE SEBI (LISTING OBLIGATION AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015
Regulatory Filings
2022-02-21 English
Centrum Capital Ltd ("Manager to the Offer") has submitted to BSE a copy of Public Announcement under Regulations 3(1) and 4 read with Regulations 13(1), 14 and 15(1) of Securities and ....
Regulatory Filings
2022-02-21 English
Updates
Regulatory Filings
2022-02-18 English
TO RECORD AND RATIFY SUPPLY AGREEMENT WITH RELATED PARTY
Regulatory Filings
2022-02-18 English
Appointment of Chief Financial Officer of the Company
Regulatory Filings
2022-02-11 English
Appointment
Regulatory Filings
2022-02-11 English
Financial Result Updates
Regulatory Filings
2022-02-11 English
Outcome of Board Meeting
Regulatory Filings
2022-02-11 English
Results for the quarter and nine months ended 31.12.2021. The Board Meeting was concluded at 1315 hours.
Regulatory Filings
2022-02-11 English
This is to intimate that the Board of Directors of the Company at their meeting held today, (i.e. Friday, the 11th Day of February, 2022), have inter alia, approved and taken on record the following:
Regulatory Filings
2022-02-11 English
Board Meeting — Financial Results
Regulatory Filings
2022-02-03 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 ,inter alia, to consider and approve 1. The Unaudited ....
Regulatory Filings
2022-02-03 English
Resignation
Regulatory Filings
2022-02-01 English
In terms of the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform that Mr. Sanjiv Kumar Dudeja, due to personal preoccupation, .
Regulatory Filings
2022-02-01 English
Board Meeting — Board meeting Rescheduled
Regulatory Filings
2022-01-19 English
The Board Meeting to be held on 27/01/2022 Stands Cancelled.
Regulatory Filings
2022-01-19 English
Board Meeting — Financial Results
Regulatory Filings
2022-01-19 English
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2022 ,inter alia, to consider and approve unaudited financial ....
Regulatory Filings
2022-01-19 English
Updates
Regulatory Filings
2022-01-12 English
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st December, 2021
Regulatory Filings
2022-01-12 English
Trading Window
Regulatory Filings
2022-01-04 English
The trading window was closed on 31 December, 2021 for all the designated persons & immediate relatives of Designated Persons.
Regulatory Filings
2022-01-04 English